Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Grabicki, I. Brodnicka, H. Batura-Gabryel, B. Brajer, B. Kuznar-Kaminska (Wolica, Poland). Coexistence of cardiovascular diseases in patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 572

Member's Comments

No comment yet.

Related content which might interest you: Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Prevalence of undiagnosed COPD in patients with established cardiovascular diseases Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype? Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Prevalence of cardiovascular disease in COPD patients in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 High prevalence of undiagnosed COPD in patients with cardiovascular disease Source: Annual Congress 2009 - Risk factors for COPD Year: 2009 Cardiovascular risk factors in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Prevalence of comorbid cardiovascular conditions in Russian patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 453s Year: 2006 Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Prevalence and associated factors of osteoporosis among patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020 Cardiovascular comorbidities in chronic obstructive pulmonary disease patients Source: International Congress 2017 – COPD biomarkers Year: 2017 Use of metoprolol succinate in patients with cardiovascular diseases associated with asthma or chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 502s Year: 2006 Exacerbations and mortality of COPD patients with cardiovascular disease in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Chronic asthma and the risk of cardiovascular disease Source: Eur Respir Monogr 2020; 88: 82-95 Year: 2020 The evaluation of systemic inflammation in COPD patients comorbided with cardiovascular diseases or diabetes mellitus Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 The association between COPD and cardiovascular disorders Source: International Congress 2017 – COPD and comorbid cardiovascular diseases Year: 2017 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007